share_log

Hill Street Provides Selected Preliminary Unaudited FY2022 Financial Results Highlights and Operations Update to Shareholders

Hill Street Provides Selected Preliminary Unaudited FY2022 Financial Results Highlights and Operations Update to Shareholders

Hill Street向股東提供精選的未經審計的2022財年財務業績亮點和運營更新
newsfile ·  2022/10/06 20:36

Toronto, Ontario--(Newsfile Corp. - October 6, 2022) - Hill Street Beverage Company Inc. (TSXV: HILL) ("Hill Street", or the "Company"), is pleased to provide a letter to all shareholders from CEO Craig Binkley, with a preview of selected preliminary unaudited financial results highlights for the three-month and twelve-month periods ended June 30, 2022 and an update on operations.

安大略省多倫多-(Newsfile Corp.-2022年10月6日)-Hill Street Beverage Company Inc.(多倫多證券交易所股票代碼:Hill)(“希爾街,或“公司“),很高興提供首席執行官克雷格·賓克利致所有股東的一封信,其中包括截至2022年6月30日的三個月和十二個月的精選初步未經審計財務業績重點預覽和最新運營情況。

Dear Hill Street Shareholders,

尊敬的Hill Street股東們:

As I stated in my August 11, 2022 Update Letter, fiscal year 2022 was by far the most successful fiscal year in the history of Hill Street. That update included a significant review of the specific operational successes of the Company throughout the year that have helped to drive our financial results. While 2022 audited financials are due at the end of this month, I want to share a preliminary view of select unaudited results which show a strong continuation of the growth trend of the business. In addition, I want to share several operational updates on our business lines to provide context for these results and to preview our evolving business initiatives as we progress through FY23.

正如我在2022年8月11日的更新信中所説,2022財年是Hill Street歷史上最成功的財年。這一最新情況包括對公司全年的具體運營成功進行了重要回顧,這些成功幫助推動了我們的財務業績。雖然2022年經審計的財務報告將於本月底到期,但我想分享對精選的未經審計業績的初步看法,這些業績顯示業務增長趨勢強勁延續。此外,我還想分享我們業務線的幾個最新運營情況,以提供這些結果的背景信息,並預覽我們在進入2013財年期間不斷髮展的業務計劃。

Stellar Q4 Performance Drove Significant Growth in Financial Metrics for Q4 and the Full Year

第四季度的出色表現推動了第四季度和全年財務指標的顯著增長

Anticipated consolidated net revenue more than doubled in Q4 of fiscal year 2022, growing a dramatic +118% vs. Q4 one year ago. Full fiscal year 2022 net revenue growth is expected to finish at a robust +42% vs. fiscal 2021, completing a very strong growth year.

預計合併淨收入在2022財年第四季度翻了一番以上,與一年前的第四季度相比大幅增長了118%。與2021財年相比,預計2022財年全年淨收入增長將達到強勁的+42%,為非常強勁的增長年度畫上句號。

Expected gross profit grew even faster than revenues. The quarter marks the first time that this key metric will have surpassed $500,000, with +127% growth vs. Q4 one year ago. Expected gross profit for the full fiscal year 2022 grew an impressive +47% vs. fiscal 2021.

預期毛利潤的增長甚至快於收入的增長。該季度標誌着這一關鍵指標將首次超過50萬美元,同比增長127%。預計2022財年的毛利潤比2021財年增長了47%,令人印象深刻。

These preliminary results evidence the Company's sustained financial performance that we have previously highlighted. Graph 1 below, which was first introduced in my April 5, 2022 CEO Letter has been updated to include the quarterly trailing 12-month figures (TTM) for net revenue and gross profit from September 2019 to June 30, 2022, an analysis period that covers the past three full fiscal years. The figures above each line represent the change vs. prior year for that metric. Additionally, the figures in the green boxes represent the gross profit margin expressed as a % of net revenue.

這些初步結果證明瞭我們之前強調的該公司的持續財務業績。下面的圖表1是在我2022年4月5日致CEO的信中首次介紹的,現已更新為包括2019年9月至2022年6月30日的季度往績12個月淨收入和毛利潤數字(TTM),這一分析期涵蓋了過去三個完整的財年。每一行上方的數字代表該指標與前一年相比的變化。此外,綠色方框中的數字表示毛利率佔淨收入的百分比。

As communicated previously, TTM net revenues have been increasing consistently between 24% and 53% since Q4 of fiscal 2020 - a period of nine quarters. TTM gross profits have been increasing even more rapidly, and the profit margin on the business has increased significantly from 31% in Q3 2020 to a sustained 52-53% for the last four quarters, including the anticipated Q4 2022 figure. Driving profitable growth is our mission and these key financial metrics indicate that we've been successful at that.

正如之前傳達的那樣,自2020財年第四季度以來,TTM淨收入一直在持續增長24%至53%-為期九個季度。TTM的毛利潤增長更快,業務利潤率從2020年第三季度的31%大幅增加到過去四個季度的52%-53%,包括預期的2022年第四季度數字。推動盈利增長是我們的使命,這些關鍵的財務指標表明我們在這方面取得了成功。

Note: The preliminary fiscal year 2022 and Q4 financial results are unaudited, subject to revision, and anticipated to be finalized and released by late October 2022. The Company's final audited financial results for the fiscal year 2022 and Q4 could differ materially from these selected preliminary results.

注:2022財年和第四季度的初步財務結果未經審計,可能會進行修訂,預計將於2022年10月下旬敲定併發布。該公司2022財年和第四季度的最終審計財務結果可能與這些選定的初步結果大不相同。

We Implemented a Significant Streamlining of the Vin(Zero) Alcohol-Free Wine Business in Q4

我們實施了顯著精簡的Vin(零)第四季度無酒精葡萄酒業務

Early in the fiscal year, we began an evaluation of our commercial operating system for Vin(Zero), with many of the recommendations from that program being implemented in Q4. We made major adjustments across all the key areas of production planning, shipping and logistics, warehousing, sales and retail distribution. We expect to see several key positive financial impacts from these changes over time. Importantly, we have:

在本財年早些時候,我們開始對我們的Vin(Zero)商業操作系統進行評估,該計劃的許多建議將於第四季度實施。我們在生產計劃、航運物流、倉儲、銷售和零售配送等所有關鍵領域都進行了重大調整。隨着時間的推移,我們預計這些變化將帶來幾個關鍵的積極財務影響。重要的是,我們有:

  • shortened our order-to-cash cycle dramatically;
  • reduced the level of working capital that we will be holding in finished goods inventory; and
  • structured our forecasting, operations planning, and inventory logistics models to create a more efficient shipping cycle that will reduce the need for more expensive temperature-controlled containers for our products.
  • 極大地縮短了訂單到現金的週期;
  • 降低我們將在產成品庫存中持有的營運資金水平;以及
  • 構建我們的預測、運營計劃和庫存物流模型,以創建更高效的運輸週期,從而減少我們產品對更昂貴的温控集裝箱的需求。

However, an important by-product of these changes is that we expect to see more dramatic quarter-to-quarter swings on the recognized revenues of this business. As we've previously explained, the alcohol-free wine business often had quarterly sales shifts resulting from depleted inventories from supply chain issues or COVID-related delays. These inventory problems often caused additional fees from retailers, multiplying the negative impact of the inefficiencies. It was therefore always our view that it was more accurate to look at the business over time to determine the true sales and financial trends.

然而,這些變化的一個重要副產品是,我們預計這項業務的公認收入將出現更戲劇性的季度波動。正如我們之前解釋過的,由於供應鏈問題或與COVID相關的延遲導致庫存耗盡,無酒精葡萄酒業務經常出現季度銷售轉變。這些庫存問題往往導致零售商支付額外費用,使效率低下的負面影響成倍增加。因此,我們一直認為,隨着時間的推移,更準確地觀察業務,以確定真實的銷售和財務趨勢。

In this new streamlined commercial model, we will be placing larger orders less frequently, but more rapidly converting those orders to revenues on the P&L and cash on the balance sheet. As a result, we will provide normalizations and longer-term trend analysis for our investors to better understand the true performance of the business.

在這種新的簡化商業模式中,我們將不那麼頻繁地下更大的訂單,但更快地將這些訂單轉化為損益表上的收入和資產負債表上的現金。因此,我們將為我們的投資者提供正常化和更長期的趨勢分析,以更好地瞭解業務的真實表現。

Q4 of fiscal 2022 got a boost in estimated revenues because we shifted our model and converted warehoused finished goods inventory to revenue and importantly, into cash. We will provide more detail on those impacts when we release the audited results.

2022財年第四季度的預計收入得到了提振,因為我們改變了模式,將倉儲產成品庫存轉換為收入,更重要的是,轉換為現金。我們將在公佈審計結果時提供有關這些影響的更多細節。

Importantly, while a lot of attention has been placed on the launches of our cannabis projects, the Vin(Zero) business has allowed us to generate cash for operations in a way that many other cannabis-related companies can't. We continue to believe in the growth opportunity of this business as we continue to expand our view beyond Canada, and we believe that the new model will be a more efficient operational and financial approach to profitably capturing that growth.

重要的是,雖然我們的大麻項目的推出受到了很多關注,但Vin(Zero)業務使我們能夠以許多其他大麻相關公司無法實現的方式為運營創造現金。我們繼續相信這項業務的增長機會,因為我們繼續將我們的視野擴展到加拿大以外,我們相信新模式將是一種更高效的運營和財務方式,以盈利地實現增長。

DehydraTECHTM Technology Licensing Business Delivered a Strong Year of Expansion and Growth

脱氫技術TM技術許可業務實現了強勁的擴張和增長

As we've said before, integrating the DehydraTECH™ licensing business into the Company following our December 2020 acquisition from Lexaria Bioscience Corp. changed our business financially, operationally, and geographically. The DehydraTECH™ rights have allowed us to build plans to fundamentally grow our business beyond Canada into global markets, beyond beverages into cannabis technology, and beyond B2C into B2B scale opportunities as we work to build a global, multi-business company pioneering the space where premium crafted consumer products meet bioscience.

正如我們之前所説的,在2020年12月收購利卡里亞生物科學公司後,將DehyTECH™許可業務整合到公司中,從財務、運營和地理位置上改變了我們的業務。德海泰克的™權利使我們能夠制定計劃,從根本上將我們的業務從加拿大擴展到全球市場,從飲料到大麻技術,從B2C到B2B規模的機會,因為我們致力於建立一家全球性的多業務公司,開創優質精心製作的消費產品與生物科學相結合的空間。

As noted previously, as of July 2021, the Company only had one DehydraTECH™ licensee operating live in-market with DehydraTECH™ THC-infused products - the owner of the "1906 Drops" line of products ("1906"), which were then available in four U.S. states, with 1906's cannabis-infused chocolate products then also available primarily in Colorado.

如前所述,截至2021年7月,本公司只有一家脱氫TECH™許可證持有人在市場上現場運營脱氫TECH™注入產品--“1906 Drops”系列產品的所有者(1906),當時在美國四個州都可以買到,1906年的注入大麻的巧克力產品當時也主要在科羅拉多州可以買到。

By the end of fiscal 2022 our U.S. footprint was up to eight states, representing a population of over 90 million people[1] (+305% vs. the 29.5MM with which we started the fiscal year) and an addressable market of $19.2B USD[2] in estimated 2022 total cannabis sales.

到2022財年末,我們在美國的足跡達到8個州,代表着9000多萬人口[1](增長305%,而本財年開始時為29.5百萬美元),潛在市場價值為192億美元[2]據估計,2022年大麻總銷量。

With 1906's expansion into Ohio and Pennsylvania in Q1 of fiscal 2023, we now have an operating footprint in the U.S. covering ten states with a total population of 115MM[3] and an addressable market of approximately $21.5B USD in estimated 2022 cannabis sales[4]. That footprint covers states generating almost two-thirds of the addressable market of $33B USD in projected total U.S. cannabis sales for 2022[5], up from our coverage of less than one-quarter of total U.S. cannabis sales at the beginning of FY 2022.

隨着1906年在2023財年第一季度向俄亥俄州和賓夕法尼亞州擴張,我們現在美國的運營足跡覆蓋了10個州,總人口為1.15億[3]預計2022年大麻銷售的潛在市場價值約為215億美元[4]。這一足跡覆蓋了2022年美國大麻銷售總額預計為330億美元的潛在市場中產生近三分之二的州[5],而在2022財年開始時,我們的覆蓋範圍不到美國大麻總銷售額的四分之一。

Expected revenues for fiscal year 2022 from DehydraTECH™ licensing are approximately $550,000 vs. just over $200,000 in fiscal year 2021. As we've previously highlighted, in fiscal year 2022, we have not yet realized the full impact of revenues expected from many of the DehydraTECH™ product launches and expansion plans of new and existing licensees that have been announced as they continue to roll out.

預計2022財年DehelTECH™許可的收入約為550,000美元,而2021財年僅略高於200,000美元。正如我們之前強調的,在2022財年,我們還沒有意識到許多DehyTECH™產品發佈的預期收入以及新的和現有的許可證獲得者在繼續推出時宣佈的擴展計劃的全部影響。

Recently Announced Expansions Are Now Hitting the Markets Live:

最近宣佈的擴展現在正在衝擊Markets Live:

  • 1906 Drops have expanded to Michigan, Pennsylvania, and Ohio in Q1 of fiscal year 2023.
  • Lume launched their brand utilizing DehydraTECH™ in Michigan dispensaries in September.
  • Neo Alternatives launched their Root 66 brand utilizing DehydraTECH™ in Massachusetts dispensaries in September.
  • Folium Farms is expected to launch their Karma brand utilizing DehydraTECH™ in Oregon in early October.
  • 在2023財年第一季度,1906 Drops已擴展到密歇根州、賓夕法尼亞州和俄亥俄州。
  • Lume於9月份在密歇根州的藥房利用DehyTech™推出了他們的品牌。
  • Neo Alternative於9月份在馬薩諸塞州的藥房推出了他們的Root66品牌,使用的是DehyTECH™。
  • Folium Farm預計將於10月初在俄勒岡州利用DehyTECH™推出他們的Karma品牌。

Importantly, this licensing business unit has a very attractive financial structure. It is a low operating expense business, with even lower capital expense required of the Company. As the revenues continue to grow and make up a greater percentage of the total consolidated financials, we expect it to continue to improve the overall financial efficiency metrics of the company and further drive our cash efficiency.

重要的是,這個許可業務部門擁有非常有吸引力的財務結構。這是一項低運營費用的業務,對公司的資本支出要求更低。隨着收入持續增長並在綜合財務總額中佔更大比例,我們預計這將繼續改善公司的整體財務效率指標,並進一步推動我們的現金效率。

We Are Re-evaluating Our Overall Cannabis Strategy for Canada and Withdrawing Our (V)ia Regal Cannabis Beverage Initiative from the Canadian market

我們正在重新評估我們在加拿大的整體大麻戰略,並將我們的(V)ia Regal大麻飲料計劃從加拿大市場上撤回

Before discussing the important strategic rationale behind our decision to withdraw our (V)ia Regal cannabis beverage initiative from the Canadian market, it is important to note that the exceptional financial numbers that I have shared earlier in this update do not include any revenues from the sale of (V)ia Regal beverages in Canada. We will provide more details when we release our audited fiscal year 2022 results, but the revenues from our Canadian cannabis beverage business were very disappointing and overall, this has turned out to be an unprofitable initiative for Hill Street due to the complexities of the business system that was put in place.

在討論我們決定從加拿大市場撤回我們的(V)ia Regal大麻飲料計劃背後的重要戰略理由之前,重要的是要注意到,我在本更新早些時候分享的特殊財務數字 包括在加拿大銷售(V)ia Regal飲料的任何收入。我們將在公佈經審計的2022財年業績時提供更多細節,但我們加拿大大麻飲料業務的收入非常令人失望,總體而言,由於實施的商業系統的複雜性,這對Hill Street來説是一個無利可圖的舉措。

Our rationale in coming to this decision was based on several factors:

我們作出這一決定的理由是基於以下幾個因素:

  1. The cannabis beverage market is in very early-stage development but is already highly saturated.
  1. 大麻飲料市場正處於非常早期的發展階段,但已經高度飽和。.

Beverages hover around only 2% cannabis market share in Canada and around 1% in the US[6]. Yet there is an exploding number of distinct products fighting for that small and relatively stable share, increasing from around ten products in June of 2020 to over 100 by January 2022 in the Canadian provinces. That type of competitive intensity often drives price and margin compression as we've seen in other markets, as brands pay to secure scarce retail space and drop pricing to compete for consumer purchases.

大麻飲料在加拿大的市場佔有率僅為2%,在美國的市場佔有率約為1%[6]。然而,在加拿大各省,有越來越多的不同產品在爭奪這一相對穩定的小份額,從2020年6月的約10種產品增加到2022年1月的100多種。就像我們在其他市場看到的那樣,這種競爭強度往往會推動價格和利潤率的壓縮,因為品牌會為確保稀缺的零售空間而付費,並通過降價來爭奪消費者的購買。

Based on my almost forty years operating in alcoholic and non-alcoholic beverages across the globe with leading companies and brands, I personally believe that the ready-to-drink (RTD) cannabis beverage market is going to take a longer time and significant capital investment to develop. Large investments in capital equipment for manufacturing have been made by LPs in Canada and the US, but it will also take additional significant investment at retail for cold drink equipment - just as we've needed those major investments to drive presence, consumer purchase and growth in other beverage categories.

基於我在全球領先公司和品牌的酒精和非酒精飲料領域近40年的運營經驗,我個人認為,即飲(RTD)大麻飲料市場的發展將需要更長的時間和大量的資本投資。加拿大和美國的有限合夥人已經在製造資本設備上進行了大量投資,但這也將需要在冷飲設備零售方面進行額外的重大投資-就像我們需要這些重大投資來推動其他飲料類別的存在、消費者購買和增長一樣。

In addition, RTD beverages have higher costs to transport, warehouse, and stock at retail due to weight and bulk vs. other edible products, so the category will always be competing with more efficient cannabis alternatives for distribution and shelf space.

此外,與其他可食用產品相比,RTD飲料在零售時的運輸、倉庫和庫存成本更高,因此這一類別將始終在分銷和貨架空間方面與更高效的大麻替代品競爭。

  1. There are significant regulatory challenges in the Canadian cannabis market.
  1. 加拿大大麻市場面臨着重大的監管挑戰。

The planning of our (V)ia Regal initiative, like many other cannabis initiatives in Canada, began before cannabis edibles were even legal, and before the final cannabis regulations were published by Health Canada. It is now well known that there are significant regulatory challenges in the Canadian cannabis market with very limited abilities to promote products.

與加拿大的許多其他大麻倡議一樣,我們的(V)ia Regal倡議的規劃甚至在大麻食用合法化之前就開始了,在加拿大衞生部公佈最終的大麻法規之前就已經開始了。現在眾所周知,加拿大大麻市場面臨着重大的監管挑戰,推廣產品的能力非常有限。

Marketing and promotion in mainstream markets provide necessary navigation for consumers and drive differentiation for brands - it's not just about delivering a product with a name and a logo. The regulatory limitations on cannabis promotion in Canada make it unfeasible for us to support a premium cost / premium priced product like (V)ia Regal. Because of Health Canada's interpretation of Canadian cannabis promotion regulations, we have had to withdraw multiple elements of our marketing tools and basic messaging around the core product proposition and ingredients. Our inability to effectively promote the brand was further exacerbated by the complex chain of cannabis licenses needed in the route to market, as we could not operate directly without our own licenses.

主流市場的營銷和推廣為消費者提供了必要的導航,並推動了品牌的差異化--這不僅僅是提供帶有名稱和標誌的產品。加拿大對大麻推廣的監管限制使我們無法支持像(V)ia Regal這樣的高成本/高價格產品。由於加拿大衞生部對加拿大大麻推廣法規的解釋,我們不得不撤回我們的營銷工具和圍繞核心產品主張和成分的基本信息的多個元素。我們無法有效地推廣這個品牌,而在進入市場的道路上需要複雜的大麻許可證鏈,這進一步加劇了我們的無力,因為我們沒有自己的許可證就不能直接運營。

  1. The (V)ia Regal business system is not financially efficient.
  1. (五)帝王集團的業務系統在財務上效率不高。

The supply chain and manufacturing model for (V)ia Regal was not financially efficient, unlike the key drivers of our success on our other two business lines. Hill Street took on significant amounts of inventory of alcohol-free wine - the base of the (V)ia Regal product, because of the long lead time order and production cycle for that base material. The alcohol-free wine imported as a bulk wine input into (V)ia Regal has a comparatively shorter shelf life than when imported as our Vin(Zero) finished goods. As we ordered bulk wine inventory based on early aggressive forecasts for the industry and, as early forecasts for the (V)ia Regal business did not materialize, we have had to write off significant amounts of that inventory due to code date expiration and spoilage.

(V)ia Regal的供應鏈和製造模式在財務上並不高效,這與我們在其他兩個業務線上取得成功的關鍵驅動力不同。Hill Street承擔了大量無酒精葡萄酒的庫存,這是(V)ia Regal產品的基礎,因為這種基礎材料的交貨期和生產週期很長。作為散裝葡萄酒進口到(V)ia Regal的無酒精葡萄酒比作為我們的Vin(Zero)成品進口的保質期相對較短。由於我們基於對行業的早期積極預測訂購了大量葡萄酒庫存,並且對(V)ia Regal業務的早期預測沒有成為現實,因此由於代碼日期過期和變質,我們不得不註銷大量庫存。

  1. The cannabis market size in Canada is relatively small vs. our US DehydraTECH™ opportunity.
  1. 與我們美國的脱氫技術™機會相比,加拿大的大麻市場規模相對較小。

The (V)ia Regal business was our first cannabis initiative in Canada and was in development well before we acquired the rights to DehydraTECH™ technology. Canada has a total population of 38MM, with addressable cannabis market sales estimated to be just under CDN $4B2 in 2021. Contrast those figures with the US population of 115MM and approximately USD $21.5B market that we are currently operating with our DehydraTECH™ footprint in the US, and it's clear that the larger opportunity for our resources is DehydraTECH™ in the US. The dramatic difference in the financial efficiency and profitability of the two cannabis businesses amplifies the rationale to prioritize the US DehydraTECH™ business.

(V)ia Regal業務是我們在加拿大的第一個大麻倡議,早在我們獲得DehyTECH™技術權利之前就已經發展起來了。加拿大的總人口為3800萬,可尋址的大麻市場銷售額估計略低於40億加元2在2021年。將這些數字與我們目前在美國運營的1.15億人口和約215億美元的市場進行對比,顯然我們的資源更大的機會是在美國的DehyTECH™。這兩家大麻業務在財務效率和盈利能力上的巨大差異,放大了優先考慮美國DehyTECH™業務的理由。

While we remain committed to developing quality options for Canadian consumers to have great-tasting drinks with THC, the (V)ia Regal results to date and overall Canadian cannabis beverage market conditions have made it such that we believe it would be prudent for us to withdraw from this market at this time and to redirect our efforts to higher and more efficient returning initiatives in our portfolio.

雖然我們仍然致力於為加拿大消費者開發高質量的選擇,以獲得口感極佳的THC飲料,但迄今為止的(V)ia Regal業績和加拿大大麻飲料的整體市場狀況使我們相信,謹慎的做法是目前退出這個市場,並將我們的努力轉向我們投資組合中更高、更高效的退貨計劃。

Therefore, we are announcing today that we have made the decision with our Health Canada‐licensed manufacturing and sales partner Molecule Inc. to no longer produce any additional quantities of (V)ia Regal Pink Grape or White Grape sparklers, the two products that we launched together. Once existing inventories of (V)ia Regal products are sold through, they will no longer be available for sale in Canada.

因此,我們今天宣佈,我們已經決定與我們的加拿大衞生部許可的製造和銷售合作伙伴分子公司,不再生產任何額外數量的(V)ia帝王粉色葡萄或白葡萄煙花,這是我們共同推出的兩種產品。一旦(V)ia Regal產品的現有庫存通過銷售,它們將不再在加拿大銷售。

Our Longer-Term View of Winning Consumer Occasions with Cannabis Beverages

我們對大麻飲料贏得消費者機會的長期看法

While we are withdrawing from the RTD cannabis beverage business in Canada at this time, we do believe that there will be global opportunities for this business in the future, as the category and commercial systems more fully develop. At the appropriate time, we expect to return to product R&D and concept development on the cannabis infused RTD beverage category utilizing our patented DehydraTECH™ technology as the backbone vs. the other technologies and ingredient systems being used across the current RTD cannabis beverage market.

雖然我們目前正在退出加拿大的RTD大麻飲料業務,但我們相信,隨着類別和商業系統的更充分發展,這項業務未來將有全球機會。在適當的時候,我們預計將重返大麻灌注型大麻飲料類別的產品研發和概念開發,利用我們的專利DehyTECH™技術作為支柱,而不是目前大麻灌注型大麻飲料市場使用的其他技術和配料系統。

In the meantime, we also continue to work on securing a licensed partner in Canada that could support a DehydraTECH™ manufacturing operation, which would allow us to potentially launch a consumer form factor that could be mixed into a consumer's favorite drink to win occasions. Interestingly, drops, mixes, elixirs and syrups are the largest segment of the cannabis beverage category in the US markets, and we are continually expanding our experience and knowledge base in those segments as we work with our US DehydraTECH™ licensees. These form factors leverage the infrastructure and presence of existing RTD beverages in the market - both at home and on premise - and allow for more individual customization of consumer beverages to their favorite types and flavors that they already buy and consume.

與此同時,我們還在繼續努力在加拿大尋找一個獲得許可的合作伙伴,以支持DehyTECH™的製造業務,這將使我們有可能推出一種消費者外形因素,可以混合到消費者最喜歡的飲料中,以贏得機會。有趣的是,滴劑、混合物、長生不老藥和糖漿是大麻中最大的一部分。飲料在美國市場,我們正在不斷地擴展我們在這些領域的經驗和知識基礎,通過與我們的美國DehyTECH™許可證獲得者合作,我們正在不斷擴大我們在這些領域的經驗和知識庫。這些外形因素利用了市場上現有的RTD飲料的基礎設施和存在-無論是在家裏還是在現場-並允許消費者根據他們已經購買和消費的最喜歡的類型和口味進行更多的個性化定製。

Lastly, we continue to evaluate options for our Mississauga, Ontario Lucknow facility but have paused any additional investments through the end of calendar 2022, as we utilize our cash on initiatives that have a higher and more immediate return.

最後,我們繼續評估我們在安大略省勒克瑙密西索加工廠的選擇,但已經暫停了任何額外的投資,直到2022年底,因為我們將我們的現金用於具有更高和更直接回報的計劃。

We Continue to Make Progress on Building Our Corporate Reputation

我們繼續在建立企業聲譽方面取得進展

As mentioned in the August update, we have now done significant work internally on the Hill Street corporate reputation strategies and plans for both B2B industry awareness and investor relations support. We are actively working with The Panther Group to help drive many of these reputation-building activities with us through their network and programs. We worked closely with them to make additional connections and introductions at two events in September 2022 - the Benzinga Capital Conference in Chicago and MJ Unpacked in Las Vegas. We will share additional programs and materials as they develop, but we believe that our exceptional business performance provides a strong foundation on which to expand and amplify our awareness and reputation.

正如8月份的更新中所提到的,我們現在已經在Hill Street的企業聲譽戰略和計劃方面做了大量的內部工作,以提高B2B行業意識和支持投資者關係。我們正在積極與黑豹集團合作,通過他們的網絡和計劃,幫助我們推動許多這樣的聲譽建立活動。我們與他們密切合作,在2022年9月的兩個活動上建立了更多的聯繫和介紹-芝加哥的Benzinga Capital Conference和拉斯維加斯的MJ Unpack。我們將分享更多正在發展的項目和材料,但我們相信,我們出色的業務表現為擴大和擴大我們的知名度和聲譽提供了堅實的基礎。

Summary

摘要

In summary, we had a transformative fiscal year 2022 with major operational advances leading to the outstanding financial performance that we've previewed here. We enter fiscal year 2023 with the impact of many of those fiscal 2022 operating successes expected to hit our financial results in FY 2023, as well as several important new wins that have already kicked off this fiscal year.

總而言之,我們經歷了一個變革性的2022財年,取得了重大的運營進展,取得了我們在這裏預覽的出色財務業績。我們進入2023財年時,受到了許多預計將在2023財年影響我們財務業績的2022財年運營成功的影響,以及本財年已經開始的幾個重要的新勝利。

We appreciate your support and hope you share our excitement about the FY22 financial results and the coming year.

我們感謝您的支持,並希望您能與我們一樣對22財年的財務業績和來年感到興奮。

Sincerely,

真誠地

Craig Binkley, CEO

克雷格·賓克利,首席執行官

About Hill Street Beverage Company Inc. (TSXV: HILL)

關於Hill Street飲料公司(多倫多證券交易所代碼:Hill)

Hill Street Beverage Company Inc. is a progressive non-alcoholic beverage and cannabis solutions company. We are pioneering the space where craft consumer products meet bioscience by combining our deep CPG expertise and our rights to use Lexaria Bioscience Corp.'s ground-breaking DehydraTECH™ patent portfolio for product development, licensing and B2B sales of cannabis ingredients.

Hill Street Beverage Company Inc.是一家進步的非酒精飲料和大麻解決方案公司。通過將我們深厚的CPG專業知識與我們使用利卡里亞生物科學公司開創性的脱氫技術™專利組合用於產品開發、許可和大麻成分的B2B銷售相結合,我們正在開創工藝消費產品與生物科學相結合的領域。

For more information on our business activities or to check out Hill Street's award-winning alcohol-free line-up and order product to be delivered straight to your home go to .

欲瞭解更多有關我們業務活動的信息或查看希爾街的屢獲殊榮的不含酒精產品陣容和訂購產品直接送貨上門.

For more information:

瞭解更多信息:

Craig Binkley, Chief Executive Officer
craig@hillstreetbevco.com.

首席執行官克雷格·賓克利
郵箱:Craig@hillstreetbevco.com。

FORWARD-LOOKING STATEMENTS

前瞻性陳述

Statements in this press release may contain forward-looking information. Any statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "would", "anticipate", "expects", and similar expressions. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances, such as future availability of capital on favourable terms, may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement. The forward-looking statements contained in this press release are made as of the date of this press release. The Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as required by securities law.

本新聞稿中的陳述可能包含前瞻性信息。本新聞稿中任何非歷史事實的陳述均可被視為前瞻性陳述。前瞻性陳述通常由諸如“可能”、“應該”、“將”、“預期”、“預期”和類似的表達方式來識別。提醒讀者,在準備任何前瞻性信息時使用的假設可能被證明是不正確的。由於許多已知和未知的風險、不確定因素和其他因素,其中許多不是公司所能控制的因素,事件或情況,如未來以有利條件獲得資本,可能會導致實際結果與預測的結果大不相同。提醒讀者不要過度依賴任何前瞻性信息。這些信息雖然在準備時被管理層認為是合理的,但可能被證明是不正確的,實際結果可能與預期的大不相同。本新聞稿中包含的前瞻性陳述明確地受到本警示性聲明的限制。本新聞稿中包含的前瞻性陳述是截至本新聞稿發佈之日作出的。除非證券法要求,否則公司不承擔公開更新或修改任何包含的前瞻性陳述的義務,無論是由於新信息、未來事件或其他原因。

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

多倫多證券交易所風險交易所及其監管服務提供商(該術語在多倫多證券交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

Not for dissemination in the United States.

不能在美國傳播。


[1] US Census Bureau,
[2] MJBiz Factbook 2022
[3] US Census Bureau,
[4] MJBiz Factbook 2022
[5] MJBiz Factbook 2022
[6] "Cannabis Beverages: A look at category trends & performance", Headset 2022 Report,

[1]美國人口普查局,
[2]MJBiz Factbook 2022
[3]美國人口普查局,
[4]MJBiz Factbook 2022
[5]MJBiz Factbook 2022
[6]《大麻飲料:品類趨勢與性能展望》,《2022年耳機報告》,

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論